New Synthesized Activating Transcription Factor 3 Inducer SW20.1 Suppresses Resistin-Induced Metabolic Syndrome

Obesity is an emerging concern globally with increasing prevalence. Obesity is associated with many diseases, such as cardiovascular disease, dyslipidemia, and cancer. Thus, effective new antiobesity drugs should be urgently developed. We synthesized SW20.1, a compound that induces activating transc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Tu T., Huang, Wei-Jan, Lin, Heng, Chen, Hsi-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295781/
https://www.ncbi.nlm.nih.gov/pubmed/37371606
http://dx.doi.org/10.3390/biomedicines11061509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295781/
https://www.ncbi.nlm.nih.gov/pubmed/37371606
http://dx.doi.org/10.3390/biomedicines11061509

Ejemplares similares